Key facts
- HTFL - Heartflow, Inc. has 17 insiders with reported activity on this page.
- Net insider value flow over the last year: -$357,502,918.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 17 Insiders of Heartflow, Inc.
- Symbol
- HTFL on Nasdaq
- Location
- San Francisco, CA
Change
- Buy value: $1,053,680; sell value: $358,556,597.
- Net share flow: -12,270,808.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$357,502,918.
Buys
$1,053,680
Shares: 40,000
Insiders: 1
Sells
$358,556,598
Shares: 12,310,808
Insiders: 8
Net
-$357,502,918
Shares: -12,270,808
Insiders: -7
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 10,215,093 | $0 | $300,022,999 | -$300,022,999 |
| 3-6 | 40,000 | 2,095,715 | $1,053,680 | $58,533,599 | -$57,479,919 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Heartflow, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10%+ Owner | $253,867,147 | -$114,998,336 | -31% | Filing P/S | 28 Apr 2026 |
| BCLS Fund III Investments, LP | 10%+ Owner | $253,867,147 | -$58,898,336 | -19% | Filing P/S | 28 Apr 2026 |
| Bain Capital Life Sciences Fund III, L.P. | 10%+ Owner | $253,867,147 | -$58,898,336 | -19% | Filing P/S | 28 Apr 2026 |
| Bain Capital Life Sciences III General Partner, LLC | 10%+ Owner | $253,867,147 | -$58,898,336 | -19% | Filing P/S | 28 Apr 2026 |
| BCLS Fund III Investments GP, LLC | 10%+ Owner | $253,867,147 | -$58,898,336 | -19% | Filing P/S | 28 Apr 2026 |
| Jeffrey C. Lightcap | Director | $217,828,174 | +$1,053,680 | +0.49% | Mixed | 24 Mar 2026 |
| John C.m. Farquhar | Chief Executive Officer, Director | $15,124,840 | -$2,413,426 | -14% | Filing P/S | 11 May 2026 |
| Campbell Rogers | Chief Medical Officer | $5,772,221 | -$5,104,879 | -47% | Mixed | 18 May 2026 |
| Vikram Verghese | Chief Financial Officer | $5,130,077 | Median | 06 May 2026 | ||
| Timothy C. Barabe | Director | $4,037,427 | Mixed | 11 Mar 2026 | ||
| Marie L. Jones | Chief Accounting Officer | $756,249 | Median | 06 May 2026 | ||
| Julie A. Cullivan | Director | $682,275 | -$446,610 | -40% | Filing P/S | 05 Mar 2026 |
| HealthCor Partners Management LP | 10%+ Owner | $0 | Mixed | 11 Aug 2025 | ||
| William C. Weldon | Director | Mixed | 07 Aug 2025 | |||
| Casey M. Tansey | Director | Mixed | 07 Aug 2025 | |||
| Wayne Joseph Riley | Director | Mixed | 07 Aug 2025 | |||
| Nicholas Downing | Director | Mixed | 07 Aug 2025 |
Top shareholders of Heartflow, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
13D/G
|
Company |
14%
from 13D/G
|
11,982,283
|
$291,528,944 | — | 31 Mar 2026 | |
| BCLS Fund III Investments, LP |
13D/G
3/4/5
|
10%+ Owner |
12%
|
10,448,158
|
$282,936,119 | -$54,160,000 | 31 Mar 2026 | |
| Hayfin Special Opportunities Fund II LP |
13D/G
|
Hayfin Management Holdings Limited |
6.2%
|
5,283,264
|
$177,834,666 | $0 | 30 Sep 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
5.7%
|
4,730,234
|
$159,219,679 | $0 | 30 Sep 2025 | |
| HealthCor Partners Management LP |
13D/G
3/4/5
|
10%+ Owner |
2.4%
|
2,082,014
|
$48,261,085 | -$106,988,264 | 24 Mar 2026 | |
| Bain Capital Life Sciences Investors, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
9.8%
from 3/4/5
|
10,448,158
|
$254,203,684 | — | 31 Mar 2026 | |
| Bain Capital Life Sciences Fund III, L.P. |
3/4/5
|
10%+ Owner |
9.8%
|
8,448,158
|
$253,867,147 | -$58,898,336 | 28 Apr 2026 | |
| Bain Capital Life Sciences III General Partner, LLC |
3/4/5
|
10%+ Owner |
9.8%
|
8,448,158
|
$253,867,147 | -$58,898,336 | 28 Apr 2026 | |
| BCLS Fund III Investments GP, LLC |
3/4/5
|
10%+ Owner |
9.8%
|
8,448,158
|
$253,867,147 | -$58,898,336 | 28 Apr 2026 | |
| BAMCO INC /NY/ |
13F
|
Company |
4.5%
|
3,827,531
|
$93,123,829 | — | 31 Mar 2026 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.5%
|
2,180,976
|
$53,063,035 | — | 31 Mar 2026 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
|
Company |
2.4%
|
2,045,938
|
$49,777,672 | — | 31 Mar 2026 | |
| Invesco Ltd. |
13F
|
Company |
2.2%
|
1,913,090
|
$46,545,480 | — | 31 Mar 2026 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.2%
|
1,893,495
|
$46,068,733 | — | 31 Mar 2026 | |
| BlackRock, Inc. |
13F
|
Company |
1.7%
|
1,462,584
|
$35,584,668 | — | 31 Mar 2026 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.6%
|
1,414,828
|
$34,422,765 | — | 31 Mar 2026 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.4%
|
1,224,326
|
$35,689,103 | — | 31 Mar 2026 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,093,417
|
$26,602,836 | — | 31 Mar 2026 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
1.3%
|
1,084,652
|
$26,389,583 | — | 31 Mar 2026 | |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC |
13F
|
Company |
1%
|
892,093
|
$21,704,623 | — | 31 Mar 2026 | |
| MORGAN STANLEY |
13F
|
Company |
0.99%
|
851,932
|
$20,727,539 | — | 31 Mar 2026 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.93%
|
793,721
|
$19,311,232 | — | 31 Mar 2026 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
756,956
|
$18,416,429 | — | 31 Mar 2026 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.88%
|
756,605
|
$18,408,200 | — | 31 Mar 2026 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.85%
|
727,667
|
$17,704,138 | — | 31 Mar 2026 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.8%
|
690,466
|
$16,799,038 | — | 31 Mar 2026 | |
| NEXT CENTURY GROWTH INVESTORS LLC |
13F
|
Company |
0.76%
|
652,969
|
$15,886,735 | — | 31 Mar 2026 | |
| 12 West Capital Management LP |
13F
|
Company |
0.75%
|
640,000
|
$15,571,200 | — | 31 Mar 2026 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.74%
|
638,306
|
$15,529,985 | — | 31 Mar 2026 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.67%
|
572,500
|
$13,928,925 | — | 31 Mar 2026 | |
| Champlain Investment Partners, LLC |
13F
|
Company |
0.66%
|
567,424
|
$13,805,426 | — | 31 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.63%
|
541,659
|
$13,181,456 | — | 31 Mar 2026 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.63%
|
538,351
|
$13,098,080 | — | 31 Mar 2026 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.58%
|
495,000
|
$12,043,350 | — | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
0.53%
|
450,550
|
$10,961,882 | — | 31 Mar 2026 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.53%
|
450,364
|
$10,957,000 | — | 31 Mar 2026 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.52%
|
446,985
|
$10,669,532 | — | 31 Mar 2026 | |
| UBS Group AG |
13F
|
Company |
0.5%
|
429,084
|
$10,439,614 | — | 31 Mar 2026 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.47%
|
403,588
|
$9,819,296 | — | 31 Mar 2026 | |
| Freestone Grove Partners LP |
13F
|
Company |
0.42%
|
362,094
|
$8,809,747 | — | 31 Mar 2026 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.4%
|
342,809
|
$8,340,543 | — | 31 Mar 2026 | |
| NZS Capital, LLC |
13F
|
Company |
0.34%
|
290,133
|
$7,058,936 | — | 31 Mar 2026 | |
| XXEC, Inc. |
13F
|
Company |
0.32%
|
278,681
|
$8,129,611 | — | 31 Mar 2026 | |
| Schusterman Interests, LLC |
13F
|
Company |
0.3%
|
259,666
|
$6,317,674 | — | 31 Mar 2026 | |
| Capricorn Investment Group LLC |
13F
|
Company |
0.3%
|
256,701
|
$6,481,342 | — | 31 Mar 2026 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.26%
|
225,000
|
$5,474,250 | — | 31 Mar 2026 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.26%
|
221,302
|
$5,384,278 | — | 31 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.26%
|
220,540
|
$5,365,738 | — | 31 Mar 2026 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.24%
|
208,814
|
$5,080,452 | — | 31 Mar 2026 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.21%
|
183,866
|
$4,473,460 | — | 31 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for Heartflow, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Campbell Rogers | HTFL | Common Stock | Sale | -10.5% | $261,266 | $28.34 | -9,219 | 78,731 | 18 May 2026 | Direct |
| Campbell Rogers | HTFL | Common Stock | Options Exercise | 11.7% | 9,219 | 87,950 | 18 May 2026 | Direct | ||
| Campbell Rogers | HTFL | Stock Options | Options Exercise | -8.33% | -9,219 | 101,410 | 18 May 2026 | Direct | ||
| John C.m. Farquhar | HTFL | Common Stock | Sale | -4.16% | $657,005 | $29.12 | -22,562 | 519,397 | 11 May 2026 | Direct |
| Marie L. Jones | HTFL | Common Stock. | Tax liability | -0.26% | -82 | 31,083 | 07 May 2026 | Direct | ||
| Campbell Rogers | HTFL | Common Stock | Tax liability | -0.8% | -637 | 78,731 | 07 May 2026 | Direct | ||
| Vikram Verghese | HTFL | Common Stock. | Tax liability | -0.22% | -473 | 210,854 | 07 May 2026 | Direct | ||
| John C.m. Farquhar | HTFL | Common Stock | Tax liability | -0.35% | -1,904 | 541,959 | 07 May 2026 | Direct | ||
| Marie L. Jones | HTFL | Common Stock. | Tax liability | -1.53% | -485 | 31,165 | 06 May 2026 | Direct | ||
| Campbell Rogers | HTFL | Common Stock | Tax liability | -2.02% | -1,634 | 79,368 | 06 May 2026 | Direct | ||
| Vikram Verghese | HTFL | Common Stock. | Tax liability | -0.72% | -1,536 | 211,327 | 06 May 2026 | Direct | ||
| John C.m. Farquhar | HTFL | Common Stock | Tax liability | -0.97% | -5,300 | 543,863 | 06 May 2026 | Direct | ||
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -10.1% | $27,733,644 | $29.23 | -948,757 | 8,448,158 | 30 Apr 2026 | See footnotes |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -10.1% | $27,733,644 | $29.23 | -948,757 | 8,448,158 | 30 Apr 2026 | See footnotes |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -10.1% | $27,733,644 | $29.23 | -948,757 | 8,448,158 | 30 Apr 2026 | See footnotes |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -10.1% | $27,733,644 | $29.23 | -948,757 | 8,448,158 | 30 Apr 2026 | See footnotes |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -10.1% | $27,733,644 | $29.23 | -948,757 | 8,448,158 | 30 Apr 2026 | See footnotes |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -7.82% | $23,411,796 | $29.37 | -797,133 | 9,396,915 | 29 Apr 2026 | See footnotes |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -7.82% | $23,411,796 | $29.37 | -797,133 | 9,396,915 | 29 Apr 2026 | See footnotes |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -7.82% | $23,411,796 | $29.37 | -797,133 | 9,396,915 | 29 Apr 2026 | See footnotes |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -7.82% | $23,411,796 | $29.37 | -797,133 | 9,396,915 | 29 Apr 2026 | See footnotes |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -7.82% | $23,411,796 | $29.37 | -797,133 | 9,396,915 | 29 Apr 2026 | See footnotes |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -2.43% | $7,752,896 | $30.51 | -254,110 | 10,194,048 | 28 Apr 2026 | See footnotes |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -2.43% | $7,752,896 | $30.51 | -254,110 | 10,194,048 | 28 Apr 2026 | See footnotes |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -2.43% | $7,752,896 | $30.51 | -254,110 | 10,194,048 | 28 Apr 2026 | See footnotes |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -2.43% | $7,752,896 | $30.51 | -254,110 | 10,194,048 | 28 Apr 2026 | See footnotes |
| Bain Capital Life Sciences Investors, LLC | HTFL | Common Stock | Sale | -2.43% | $7,752,896 | $30.51 | -254,110 | 10,194,048 | 28 Apr 2026 | See footnotes |
| John C.m. Farquhar | HTFL | Common Stock | Sale | -3.95% | $602,857 | $26.72 | -22,562 | 549,163 | 10 Apr 2026 | Direct |
| Campbell Rogers | HTFL | Common Stock | Sale | -44.3% | $1,590,093 | $24.64 | -64,533 | 81,002 | 01 Apr 2026 | Direct |
| Campbell Rogers | HTFL | Common Stock | Options Exercise | 85.4% | 67,017 | 145,535 | 01 Apr 2026 | Direct | ||
| Campbell Rogers | HTFL | Stock Option | Options Exercise | -94.8% | -60,168 | 3,298 | 01 Apr 2026 | Direct | ||
| Campbell Rogers | HTFL | Stock Options | Options Exercise | -100% | -6,849 | 0 | 01 Apr 2026 | Direct | ||
| Jeffrey C. Lightcap | HTFL | Common Stock | Other | 515.6% | 206,261 | 246,261 | 24 Mar 2026 | Direct | ||
| HealthCor Partners Management LP | HTFL | COMMON STOCK | Other | -100% | -4,615,542 | 0 | 24 Mar 2026 | By HCPCIV I, LLC | ||
| Campbell Rogers | HTFL | Common Stock | Sale | -45.1% | $1,658,033 | $25.69 | -64,533 | 78,518 | 19 Mar 2026 | Direct |
| Campbell Rogers | HTFL | Common Stock | Options Exercise | 88.1% | 67,017 | 143,051 | 19 Mar 2026 | Direct | ||
| Campbell Rogers | HTFL | Stock Option | Options Exercise | -32.1% | -67,017 | 141,510 | 19 Mar 2026 | Direct | ||
| John C.m. Farquhar | HTFL | Common Stock | Sale | -1.67% | $243,125 | $25.00 | -9,725 | 571,725 | 18 Mar 2026 | Direct |
| Timothy C. Barabe | HTFL | Common Stock | Options Exercise | 5.07% | 8,667 | 179,521 | 11 Mar 2026 | Direct | ||
| Timothy C. Barabe | HTFL | Stock Option | Options Exercise | -36% | -8,667 | 15,412 | 11 Mar 2026 | Direct | ||
| John C.m. Farquhar | HTFL | Common Stock | Sale | -2.16% | $290,886 | $22.66 | -12,837 | 581,450 | 10 Mar 2026 | Direct |
| John C.m. Farquhar | HTFL | Common Stock | Award | 0.44% | 2,631 | 594,287 | 06 Mar 2026 | Direct | ||
| Julie A. Cullivan | HTFL | Common Stock | Sale | -25% | $228,050 | $25.00 | -9,122 | 27,291 | 05 Mar 2026 | Direct |
| Timothy C. Barabe | HTFL | Common Stock | Options Exercise | 1.48% | 2,497 | 170,854 | 17 Feb 2026 | Direct | ||
| Timothy C. Barabe | HTFL | Stock Option | Options Exercise | -100% | -2,497 | 0 | 17 Feb 2026 | Direct | ||
| Campbell Rogers | HTFL | Common Stock | Sale | -46.2% | $1,595,486 | $24.49 | -65,153 | 76,034 | 12 Feb 2026 | Direct |
| Campbell Rogers | HTFL | Common Stock | Options Exercise | 90.4% | 67,016 | 141,187 | 12 Feb 2026 | Direct | ||
| Campbell Rogers | HTFL | Stock Option | Options Exercise | -100% | -67,016 | 0 | 12 Feb 2026 | Direct | ||
| John C.m. Farquhar | HTFL | Common Stock | Sale | -3.67% | $619,553 | $27.46 | -22,562 | 591,656 | 10 Feb 2026 | Direct |
| Marie L. Jones | HTFL | Common Stock. | Award | 215.8% | 21,629 | 31,650 | 06 Feb 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.